3/253/1707016352

您所在的位置:网站首页 3/253/1707016352  
§ 253 HGB

发布时间:2024-07-17
企業情報

发布时间:2024-07-17
高清正版 JGJ∕T 253

发布时间:2024-07-17
Are Mendelian randomization investigations immune from

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/33611685Are Mendelian randomization investigations immune from …网页Eur J Epidemiol. 2021 Mar;36 (3):253-257. doi: 10.1007/s10654-021-00726-8. Epub 2021 Feb 21. Are Mendelian randomization investigations immune from bias due to reverse causation?

发布时间:2024-07-17
Article R253

发布时间:2024-07-17
Neutral sphingomyelinase inhibition alleviates apoptosis but

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/28277984Neutral sphingomyelinase inhibition alleviates apoptosis, but …网页Previous studies have revealed the activation of neutral sphingomyelinase (N-SMase)/ceramide pathway in hepatic tissue following warm liver ischemia reperfusion (IR) injury. Excessive ceramide accumulation is known to potentiate apoptotic stimuli and a link between apoptosis and endoplasmic reticulu …

发布时间:2024-07-17
Biological therapy for severe asthma

data-id="" iid="">PubMedhttps://pubmed.ncbi.nlm.nih.gov/37148024Biological therapy for severe asthma - Indian perspectives …网页The present review dissects and summarises the available monoclonal antibodies for asthma treatment in India, the perspectives of Indian patients on biological therapy, and the challenges encountered by patients and physicians in this regard. We provide practical suggestions for utilising monoclonal antibodies and deciding on the optimal agent ...

发布时间:2024-07-17

今日新闻


    推荐新闻


    专题文章

      CopyRight 2018-2019 实验室设备网 版权所有